Sarcopenia
Conditions
Brief summary
Objective: To assess the effect of different post-exercise oral nutritional supplement intake timing on sarcopenia indicators in hemodialysis patients. Study Design: 24-weeks Randomized Control Trial (RCT), includes 12-wk intervention period and 12-week follow up period. Setting & Participants: Maintenance hemodialysis patients who were older than 20 years old meet sarcopenia diagnosis criteria. Intervention: Group A: During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise. Participants take oral supplement in 1 to 2 hours after exercise program. Group B: Participants have the same exercise program and oral supplement as Group A. However, they take oral supplement in 2.5-4 hours after exercise program. Group C: Participants only take oral supplement. Control group: Participants maintain usual diet and physical activity without any intervention.
Interventions
OTHER1 hour combined intervention ( Exercise and nutrition)
Subjects take oral supplement after exercise in the time period between 1-2 hours. They will take oral supplement during hemodialysis treatment.
OTHER3 hours combined intervention ( Exercise and nutrition)
All procedures between 1 hour combined intervention and 3 hours combined intervention are the same. The only one different is the time interval between exercise and nutrition. In this arm, the time interval of exercise and nutrition is 2.5 to 4 hours. When we recruiting subjects, all interventions will be clearly introduced to them, including the same and the different parts among them.
DIETARY_SUPPLEMENTNutrition intervention
Subjects only take oral supplement during hemodialysis treatment. The oral supplement is the same as the 1 hour combined intervention and 3 hours combined intervention.
Sponsors
China Medical University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Hemodialysis treatment longer than 3 months * Hemodialysis treatment 3 times treatment per weeks * Kt/V≥1.2 or URR≥65% * Taking foods by oral * Meeting the criteria of sarcopenia.
Exclusion criteria
* Soy allergy * Amputation * Significantly edema * Receiving palliative care * Severe angina * Unstable arrhythmias * Severe infection * Heart failure (class 4 of New York Heart Association scale) * Central venous catheter or femoral arteriovenous fistula * Pacemaker * Pregnancy * Severe paleness * Severe difficulty breathing * Chest pain * Hospitalization 3 months before recruited in this study * Oral supplement intolerance diagnosed by the doctor or dietitian * Bone injury/nerve damage/cognition impairment affecting physical activity intervention
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Appendicular skeletal muscle mass | Change from baseline appendicular skeletal muscle mass at 3 months | The weight of appendicular skeletal muscle mass. This is one of the sarcopenia indicator. |
| Muscle strength | Change from baseline muscle strength at 3 months | The measurement of handgrip strength. This is one of the sarcopenia indicator. |
| Physical performance | Change from baseline physical performance at 3 months | Measuring whether the of 6-meter walk is less than 1.0 m/s or not. This is one of the sarcopenia indicator. |
Countries
Taiwan
Outcome results
None listed